Retatrutide

Dhs. 1,658.00 AED

In stock

RЕТА is a next-generation synthetic peptide classified as a triple agonist. It simultaneously targets three hormonal receptors: GLP-1, GIP, and glucagon receptors. PurePeptides offers РЕТА for research purposes focused on appetite regulation, energy balance, and carbohydrate metabolism, with a purity of over 99%.

The compound belongs to the class of incretin mimetics, substances that mimic the action of the body's natural hormones. Its triple-agonist mechanism distinguishes it from earlier agents that target one or two receptors, making it a subject of interest in metabolic research.

The triple-agonist mechanism involves three receptors studied in laboratory and clinical models:

GLP-1 receptors — associated with appetite regulation and insulin secretion, with relevant pathways involving the hypothalamus and pancreas.
GIP receptors — found in pancreatic beta cells and adipose tissue, where they are studied in relation to insulin sensitivity and lipid metabolism.
Glucagon receptors — primarily associated with the liver and also studied in the context of energy expenditure and fat metabolism.

The compound is being investigated in clinical research programs related to body weight regulation and metabolism. These findings belong to a scientific research context and should not be interpreted as evidence of effects in individual consumers.

The product is supplied in a syringe pen with a fixed concentration and volume. Specific batch details are provided on the product page. Store the pen under refrigeration, avoiding freezing and direct light, in accordance with the manufacturer's instructions.

We deliver throughout Dubai. Once you place your order, our manager will contact you to confirm product availability. Payment is due after your order has been confirmed.